title: Screening for high risk human papilloma virus (HR-HPV) subtypes, among Sudanese patients with oral lesions.
abstract: HR-HPV subtypes are strongly linked to etiology of many human cancers including oral cancer. The epidemiology of infection with different HPV genotypes greatly varies in different countries. The aim of this study was to identify and genotype the HR-HPV subtypes in oral tissues obtained from Sudanese patients with oral lesions. In this retrospective study 200 patients with oral lesions were screened by molecular methods (PCR) for the presence of HR-HPV subtypes. Of the 200 patients, 100/200 were patients with oral cancer (ascertained as case group) and 100/200 were patients with non-neoplastic oral lesions (ascertained as control group). Out of the 200 patients, 12/200 (6%) were found with HR-HPV infection. Of the 12 positive patients, 8/12 (66.7%) were among cases and the remaining 4/12 (33.3%) were among control group. The distribution of different genotypes was: type HPV 16 6/12 (50%), HPV18 4/12 (34%), HPV 31 1/12 (8%) and HPV 33 1/12 (8%). In view of these findings, HPV particularly subtypes 16 and 18 play a role in the etiology of oral cancer in the Sudan.
authors: Department of Histopathology and Cytology, College of Medical Laboratories Science, Sudan University for Sciences and Technology Sudan.
authors: Ali Yousif
authors: AY
authors: Babiker
authors: Faris Margani
authors: FM
authors: Eltom
authors: Mohamed S
authors: MS
authors: Abdalaziz
authors: Arshad
authors: A
authors: Rahmani
authors: Saadalnour
authors: S
authors: Abusail
authors: Hussain Gadelkareem
authors: HG
authors: Ahmed
keywords: HR- HPV; Oral lesions; PCR; Toombak; smoking
references: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references: 15734974
references: Ecancermedicalscience. 2012;6:282
references: 23226164
references: J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
references: 14652239
references: Oman Med J. 2012 May;27(3):201-6
references: 22811767
references: Gend Med. 2008 Dec;5(4):385-94
references: 19108811
references: Oncol Rep. 2012 Nov;28(5):1750-6
references: 22923266
references: J Oral Pathol Med. 2007 Sep;36(8):482-7
references: 17686007
references: BMJ. 2002 Apr 6;324(7341):799-800
references: 11934759
references: Cancer Res. 1988 Jun 1;48(11):3282-7
references: 3365707
references: Oral Oncol. 2005 Mar;41(3):244-60
references: 15743687
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):311-5
references: 15716837
references: Int J Cancer. 2009 Jul 15;125(2):362-6
references: 19330833
references: Oral Oncol. 2009 Apr-May;45(4-5):309-16
references: 18804401
references: Dent Clin North Am. 2005 Jan;49(1):143-65, ix
references: 15567366
references: Anticancer Res. 2000 Sep-Oct;20(5A):2855-60
references: 11062693
references: J Clin Virol. 2011 Jun;51(2):100-4
references: 21527208
references: J Cancer Res Ther. 2007 Apr-Jun;3(2):127-30
references: 17998740
references: Semin Oncol. 2004 Dec;31(6):744-54
references: 15599852
references: N Engl J Med. 2007 May 10;356(19):1944-56
references: 17494927
references: Asian Pac J Cancer Prev. 2012;13(12):6083-6
references: 23464408
references: Oral Oncol. 2002 Apr;38(3):227-34
references: 11978544
references: Int J Cancer. 1999 May 17;81(4):527-34
references: 10225439
references: J Natl Cancer Inst. 2000 May 3;92(9):709-20
references: 10793107
references: Anticancer Res. 2002 May-Jun;22(3):1445-51
references: 12168821
references: J Cancer Res Clin Oncol. 2012 Jan;138(1):103-9
references: 22033727
references: N Engl J Med. 2003 Feb 6;348(6):518-27
references: 12571259
references: Head Neck. 2009 Nov;31(11):1393-422
references: 19787782
references: JAMA. 2012 Feb 15;307(7):693-703
references: 22282321
references: Science. 1991 Nov 22;254(5035):1167-73
references: 1659743
references: Int J Clin Exp Pathol. 2012;5(9):965-71
references: 23119114
references: Cad Saude Publica. 2007 Mar;23(3):553-64
references: 17334570